Skip to main content

Advertisement

Table 2 The risk factors of recurrence after esophageal variceal eradication by endoscopic therapies

From: The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study

  Within 1 year recurrence group (n = 89) 1–3 years recurrence(n = 54) Without variceal recurrence group(n = 10) P value
Gender
 Male(n,%) 58, 65.2 36, 66.7 6, 60 0.91
 Female(n,%) 31, 34.8 18, 33.3 4, 40
Endoscopic treatment 0.02
 EVL(n,%) 39, 43.8 14, 25.9 1, 10  
 EIS(n,%) 39, 43.8 32, 59.3 9, 90
 EVL + EIS(n,%) 11, 12.4 8, 14.8 0, 0
Variceal diameter(cm) 1.22 ± 0.31 1.20 ± 0.3 0.9 ± 0.2 0.03
Red signs before treatment(Y/N) 68/21 36/18 5/5 0.14
Gastric varices(Y/N) 26/63 13/41 0/10 0.13
Diameter of peri-ECV(mm) 3.7 ± 1.4 2.5 ± 1.1 1.7 ± 0.9 0.0
Existence or not of PFV (Y/N) 57/32 2/52 0/10 0.0
Diameter of PFV(mm) 1.9 ± 1.6 0.1 ± 0.4 0 0.0
Diameter of para-ECV(mm) 6.5 ± 2.2 5.9 ± 1.9 6.9 ± 3.7 0.28
Primary/secondary preventions(n) 15/74 13/41 3/7 0.44
Child-Pugh grade(n,%) 0.04
 A 49, 55.1 39, 72.2 8, 80  
 B 27, 30.3 14, 25.9 2, 20
 C 13, 14.6 1, 1.9 0, 0
Child-Pugh score 7.3 ± 2.1 6.5 ± 1.4 6.4 ± 0.9 0.025
MELD score 7.1 ± 7.8 6.9 ± 4.9 5.3 ± 2.0 0.72
CT angiography
 Veins around the esophagus(Y/N) 81/8 50/4 9/1 0.93
 Veins around fundus (Y/N) 63/26 38/16 6/4 0.77
 Other collateral vein(Y/N) 12/77 11/43 2/8 0.53
 Portal vein embolus(Y/N) 25/64 10/44 3/7 0.41
With liver cancer/cirrhosis 8/81 9/45 2/8 0.31
Etiology of cirrhosis(n, %) 0.28
 hepatitis B 60, 67.4 33, 61.1 7, 70  
 hepatitis C 2, 2.2 8, 14.8 1, 10
 alcoholic liver disease 14, 15.7 4, 7.4 1, 10
 nonalcoholic fatty liver disease 6, 6.8 3, 5.6 1, 10
 autoimmune liver disease 6, 6.8 4, 7.4 0, 0
 unknown causes 1, 1.1 2, 3.7 0, 0